Gross Margin

A new report slams the FDA for blocking vital treatments with rising costs and denials, but the agency faces a complex reality of reform and internal pressure.

A Florida firm says its 15-year study proves 'Hypergrowth Stocks' are a unique asset class. But can a 40% growth metric truly redefine investing?

Cocoa prices are falling, but your chocolate bar costs more. Discover why consumers are embracing this shift by reaching for premium, pricier treats.

As Milestone Scientific prepares its year-end call, investors look for signs of a turnaround and growth for its advanced injection technology.

Interlink Electronics reports a wider Q4 loss but makes key moves in autonomous vehicle and robotic surgery sensors, signaling a major strategic pivot.

As Spotify preps its Q1 2026 results, investors are watching closely. Can the audio giant sustain its growth while boosting profits amid new price hikes?

In a major leadership shuffle, co-founder Kevin McCrystle will take the CEO reins to steer the company's focus toward AI, data services, and M&A.

With its 32nd straight dividend hike and a $100M buyback, Wiley leverages strong Q3 results and AI momentum to underscore its financial health.

Despite revenue growth, ICAPE Group posts a net loss after deciding to close two plants, signaling a pivot to a leaner model focused on innovation.

As big banks retreat, private lenders and small investors are revitalizing neighborhoods and adding homes to a market in desperate need of supply.

Strong product sales and innovation clash with a steep service decline in Europe, forcing Enerpac to restructure and adjust its outlook for 2026.

The successful launch of rosacea treatment Emrosi™ generated $14.7M, driving Journey Medical's revenue to $61.9M and signaling a major strategic win.

Adhesives giant H.B. Fuller expands margins and raises its 2026 outlook, signaling operational strength amid market softness and supply chain turmoil.

The smart glasses maker reports record sales driven by niche products, yet continued investment in global expansion keeps the company in the red for now.

The MEMS specialist saw revenue dip on a sharp medical decline, but booming aerospace sales, a higher margin, and a new dividend signal a strategic pivot.

With adjusted EPS up 20.8%, HighCo's strategic acquisitions and focus on promotion activation signal a new era of specialized growth and market leadership.

Facing a historic downturn and geopolitical turmoil, the chemical industry gathers in Texas to debate its strategy for survival and transformation.

As safety tech fills our roads, Autel's newly ASE and I-CAR accredited ADAS program aims to fix a critical skills gap and ensure vehicle safety.

Two years in, Jennifer Sey's XX-XY Athletics has turned polarizing advocacy into millions in revenue, shaking up the sports apparel industry.

Global Battery Materials ships its first graphite samples and opens a Quebec lab, a major step toward a secure, ex-China battery supply chain for North America.